Maria Zannes Bio Affinity Technologies, Inc. (BIAF) insider trading activity

Maria Zannes is President & CEO of bioAffinity Technologies, Inc.. Currently has a direct ownership of 280,359 shares of BIAF, which is worth approximately $190,644. The most recent transaction as insider was on Jan 10, 2025, when has been sold 37,037 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 280K

15.22% 3M change

99.16% 12M change

Total Value Held $190,644

Maria Zannes Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 10 2025	BUY Grant, award, or other acquisition	-	37,037 Added 11.67%	280,359 Common Stock
Jul 01 2024	BUY Grant, award, or other acquisition	-	33,784 Added 12.19%	243,322 Common Stock
Jun 12 2024	BUY Grant, award, or other acquisition	-	8,296 Added 3.81%	209,538 Common Stock
Apr 08 2024	SELL Payment of exercise price or tax liability	$74,899 $2.65 p/Share	28,264 Reduced 12.32%	201,242 Common Stock
Apr 08 2024	BUY Exercise of conversion of derivative security	$75,223 $1.16 p/Share	64,848 Added 22.03%	229,506 Common Stock
Jan 31 2024	BUY Grant, award, or other acquisition	-	23,885 Added 12.67%	164,658 Common Stock
Jan 01 2024	BUY Grant, award, or other acquisition	$18,748 $1.48 p/Share	12,668 Added 8.26%	140,773 Common Stock
Oct 01 2023	BUY Grant, award, or other acquisition	$18,749 $1.58 p/Share	11,867 Added 8.48%	128,105 Common Stock
Jul 01 2023	BUY Grant, award, or other acquisition	$18,748 $1.83 p/Share	10,245 Added 8.1%	116,238 Common Stock
Jun 06 2023	BUY Grant, award, or other acquisition	$49,999 $1.91 p/Share	26,178 Added 19.81%	105,993 Common Stock
Apr 15 2023	BUY Grant, award, or other acquisition	$18,748 $1.89 p/Share	9,920 Added 11.05%	79,815 Common Stock
Jan 01 2023	BUY Grant, award, or other acquisition	$18,757 $2.28 p/Share	8,227 Added 10.53%	69,895 Common Stock
Nov 17 2022	BUY Grant, award, or other acquisition	-	18,099 Added 22.69%	61,668 Common Stock
Sep 06 2022	BUY Conversion of derivative security	$99,422 $4.2 p/Share	23,672 Added 35.2%	43,569 Common Stock
Aug 31 2022	BUY Open market or private purchase	-	16,326 Added 45.07%	19,897 Common Stock

Maria Zannes

President & CEO

San Antonio, TX

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BIAF shares.

Notify only if

Value

Insider Trading

Get notified when an Bio Affinity Technologies, Inc. insider buys or sells BIAF shares.

Notify only if

Operation

Value

Type

News

Receive news related to bioAffinity Technologies, Inc.

Track Activities on BIAF

Account